| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/02/2000 | EP0975801A1 METHODS FOR SCREENING FOR ANTIMICROBIALS UTILIZING (aarC) AND COMPOSITIONS THEREOF |
| 02/02/2000 | EP0975790A1 New method for isolating polysaccharides |
| 02/02/2000 | EP0975768A2 Phenolic acid esterase and use thereof |
| 02/02/2000 | EP0975745A1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/02/2000 | EP0975738A1 A new microorganism streptomyces exfoliatus yj-118 and a method for producing pravastatin sodium by using the strain |
| 02/02/2000 | EP0975725A2 Detergent composition |
| 02/02/2000 | EP0975326A1 Topical application of enzymes using a peelable film |
| 02/02/2000 | EP0866855A4 Method of producing alpha 2,3-sialyltransferase |
| 02/02/2000 | EP0777683B1 Antiprotozoal cyclic tetrapeptides |
| 02/02/2000 | EP0775210B1 Mutated penicillin g acylase genes |
| 02/02/2000 | EP0729580B1 Method of identifying hdm-2-specific antibodies |
| 02/02/2000 | EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/02/2000 | EP0670890B2 Bioreactor with immobilized lactic acid bacteria and the use thereof |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020464 Isolated Smad protein |
| 02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
| 02/01/2000 | US6020306 Receptor-type tyrosine kinase and use thereof |
| 02/01/2000 | US6020293 Mixture of cellulase, water soluble carbonate salt, acid,surfactant and thickener |
| 02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
| 02/01/2000 | US6020180 C. antarctica lipase and lipase variants |
| 02/01/2000 | US6020177 Heptaprenyl diphosphate-synthetase |
| 02/01/2000 | US6020176 Converting copalyl pyrophosphate to ent-kaurene and are useful for the regulation of plant growth. |
| 02/01/2000 | US6020171 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020168 Porcine CNP gene and precursor protein |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020151 Process for the production of 7-ADCA via expandase activity on penicillin G |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 01/27/2000 | WO2000004181A1 Process for the production of mannitol by immobilized micro-organisms |
| 01/27/2000 | WO2000004179A1 Stereoselective reductive amination of ketones |
| 01/27/2000 | WO2000004178A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | WO2000004172A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | WO2000004136A1 Glucoamylase variants |
| 01/27/2000 | WO2000004134A1 Novel gene and transformant carrying the same |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000003722A1 Nocathiacin antibiotics |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | CA2337635A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | CA2337398A1 Nocathiacin antibiotics |
| 01/27/2000 | CA2337230A1 Stereoselective reductive amination of ketones |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2333912A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | CA2331340A1 Glucoamylase variants |
| 01/26/2000 | EP0974670A2 Process for producing optically active N-substituted azetidine-2-carboxylic acid compound |
| 01/26/2000 | EP0974669A1 PROCESS FOR PREPARING $g(a)-HYDROXY ACIDS USING MICROORGANISM AND NOVEL MICROORGANISM |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974661A1 Geranyl diphosphate synthase genes |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974658A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(STREPTOCOCCUS PYOGENES) |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
| 01/26/2000 | EP0974647A1 Process for producing target substances by fermentation |
| 01/26/2000 | EP0974644A1 Method for producing freeze resitant yeast |
| 01/26/2000 | EP0974268A1 Bifidobacterium-fermented milk and process for producing the same |
| 01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
| 01/26/2000 | EP0973924A1 Recombinant chimeric viruses and uses thereof |
| 01/26/2000 | EP0973916A1 Composition and method for inducing an immune response against tumour-related antigens |
| 01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 01/26/2000 | EP0973882A1 DEVELOPMENT OF HIGH-ETHANOL RESISTANT $i(ESCHERICHIA COLI) |
| 01/26/2000 | EP0973881A2 Mycobacterium recombinant vaccines |
| 01/26/2000 | EP0973875A1 Storage-stable liquid formulation comprising a laccase |
| 01/26/2000 | EP0973869A1 Method for increasing the growth of plant cell cultures |
| 01/26/2000 | EP0973864A1 Novel microorganisms |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973800A1 Novel receptor |
| 01/26/2000 | EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/26/2000 | EP0670677B1 Potentiator of Bacillus pesticidal activity |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018097 Transgenic mice expressing human insulin |
| 01/25/2000 | US6018038 Incompatible plant and pathogen interaction related gene |
| 01/25/2000 | US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease |
| 01/25/2000 | US6018023 Kainate-binding, human CNS receptors of the EAA3 family |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling |
| 01/25/2000 | US6017871 Protease-containing cleaning compositions |
| 01/25/2000 | US6017870 From fermentation of trichoderma |
| 01/25/2000 | US6017762 An ascomycetes fungus strain transformed with a cassette for expressing an aspartic protease precursor; production of cooked cheeses |
| 01/25/2000 | US6017748 Cloning host organisms |
| 01/25/2000 | US6017743 Dna which codes for a glycosyltransferase which adds oligosialic acids to glycoproteins and glycolipids; for anticarcinogenic/antimetastasis/antiinflammatory agents; for maturation of sperm and reactivation of nervous tissues |
| 01/25/2000 | US6017736 High yield process by base exchange reaction between pyrimidine nucleoside and purine base in phosphate ion-containing aqueous solution in presence of purine and pyrimidine nucleoside phosphorylases |
| 01/25/2000 | US6017726 Efficient process for producing 7-aminodeacetyl-cephalosoporanic acid by culturing penicillium chrysogenum with adipic acid, salt or ester to produce adipoyl-6-aminopenicillanic acid, then enzymatically altering molecule |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017714 Netrins |